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Objectives This study sought to examine the contemporary outcomes of retrograde chronic total
occlusion (CTO) interventions among 3 experienced U.S. centers.
Background The retrograde approach, pioneered and developed in Japan, has revolutionized the
treatment of coronary CTO, yet limited information exists on procedural efﬁcacy, safety, and repro-
ducibility of outcomes in other settings.
Methods Between 2006 and 2011, 462 consecutive retrograde CTO interventions were performed at
3 U.S. institutions. Patient characteristics, procedural outcomes, and in-hospital clinical events were
ascertained.
Results Mean patient age was 65  9.7 years, 84% were men, and 50% had prior coronary artery by-
pass surgery. The CTO target vessel was the right coronary artery (66%), circumﬂex (18%), left anterior
descending artery (15.5%), and left main artery or bypass graft (0.5%). The retrograde approach was used
as the primary method in 46% of cases and after failed antegrade recanalization in 54%. Retrograde col-
lateral vessels were septal (68%), epicardial (24%), and bypass grafts (8%). Technical and procedural suc-
cess was 81.4% (n  376) and 79.4% (n  367), respectively. The mean contrast volume and ﬂuoroscopy
time were 345  177 ml and 61  40 min, respectively. A major complication occurred in 12 patients
(2.6%). In multivariable analysis, years since initiation of retrograde CTO percutaneous coronary interven-
tion (PCI) at each center, female sex, and ejection fraction 40% were associated with higher technical
success.
Conclusions Among selected U.S. programs, retrograde CTO PCI is often performed in patients with
prior coronary bypass graft surgery and is associated with favorably high success and low complication
rates. (J Am Coll Cardiol Intv 2012;5:1273–9) © 2012 by the American College of Cardiology Foundation
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1274The introduction of coronary chronic total occlusion (CTO)
recanalization through retrograde collaterals has offered
incremental procedural success and clinically meaningful
benefit to traditional antegrade methods (1,2). Initially
developed in Japan (1–6) and advanced throughout other
Asian countries and Europe (7,8), limited experience re-
garding the performance and outcomes of retrograde CTO
percutaneous coronary intervention (PCI) has been reported
from North American centers (9,10). The present study
describes the practice patterns, procedural outcomes, and
in-hospital clinical events associated with retrograde CTO
PCI among 3 selected programs within the United States,
each representing a varied operator group and hospital
structure.
Methods
Patient population. Between January 2006 and November
011, consecutive patients undergoing retrograde CTO
CI were prospectively identified and outcomes were ret-
rospectively examined at 3 cen-
ters within the United States: St.
Joseph Medical Center, Belling-
ham Washington; Piedmont
Heart Institute, Atlanta Geor-
gia; and Veterans Affairs North
Texas Health Care System, Dal-
las, Texas. The study was ap-
proved by the Institutional Re-
view Board of each institution.
Study endpoints and deﬁnitions.
Coronary CTO were defined as
angiographic evidence of a total
occlusion with TIMI (Throm-
bolysis In Myocardial Infarction) flow grade 0 or 1 and
estimated duration of at least 3 months. Estimation of
occlusion duration was based on the following: first onset of
anginal symptoms; prior history of myocardial infarction in
the target vessel territory; or comparison with a prior
angiogram. Patients were considered to have had retrograde
CTO PCI if a guidewire was introduced into a collateral
channel that supplied the target CTO vessel distal to the
lesion.
Technical success was defined as successful CTO recan-
alization by any method (either retrograde and/or ante-
grade), with achievement of 50% residual diameter steno-
is within the treated segment and restoration of TIMI
rade 3 antegrade flow. Procedural success was defined as
chievement of technical success without in-hospital major
dverse cardiac events. In-hospital major adverse cardiac
vents included any of the following adverse events before
ospital discharge: death from any cause; Q-wave myocar-
ial infarction; recurrent angina requiring urgent repeat
Abbreviations
and Acronyms
CABG  coronary artery
bypass graft
CART  controlled
antegrade and retrograde
tracking
CTO  chronic total
occlusion
PCI  percutaneous
coronary intervention
TIMI  Thrombolysis In
Myocardial Infarctionarget vessel revascularization with PCI or coronary bypass dsurgery; or tamponade requiring pericardiocentesis or
surgery.
Statistical analysis. Clinical characteristics, angiographic
measures, and in-hospital outcomes were reported using
descriptive statistics. Continuous variables are presented as
mean  SD and were compared using the Student t test or
Wilcoxon rank-sum test. Categorical variables are expressed
as percentages and were compared using the chi-square or
the Fisher exact test, as appropriate. Logistic regression
analysis was performed to identify predictors of technical
success. Variables with p  0.25 on univariable analysis
age, sex, years since initiation of retrograde CTO PCI at
ach center, ejection fraction 40%, and prior PCI) were
ncluded in the model as well as diabetes, history of
yocardial infarction, and prior coronary artery bypass graft
urgery (CABG), variables known to be associated with
ore advanced coronary artery disease and more challeng-
ng PCI. All statistical analyses were performed with JMP
version 9.0, SAS Institute, Cary, North Carolina).
esults
Patient characteristics. During the study period, retrograde
CTO PCI was performed in 462 of 1,374 (34%) consecutive
patients undergoing CTO PCI among 3 CTO programs in
the United States: St. Joseph Medical Center, Bellingham,
Washington (n  270); Piedmont Heart Institute, Atlanta,
Georgia (n  127); Veterans Affairs North Texas Health
Care System, Dallas, Texas (n  65). A single operator
(W.L.) performed all retrograde CTO PCI cases at St.
Joseph’s, 5 operators (D.K., N.L., A.K., H.C., D.K.) at
Piedmont Heart Institute, and 2 operators (E.S.B., S.B.) at
Veterans Affairs North Texas Health Care System. Table 1
represents the clinical and angiographic characteristics of
the study population. Overall, most patients were men with
mean age of 65  9.7 years. Notably, one-half of the
patients had prior CABG, and nearly one-half of all patients
were diabetic (45%), had experienced prior myocardial
infarction (48%), or had prior PCI (45%).
The target vessel in most patients was the right coronary
artery (66%), followed by nearly equal proportions of the left
circumflex and left anterior descending arteries. Prior failed
attempted CTO at recanalization had occurred in 18% of
the patients.
Procedural characteristics and outcomes. A procedural
trategy involving primary retrograde CTO recanalization
as employed in 46% of cases with a retrograde method
sed after failed initial antegrade crossing in the remaining
Table 1). The retrograde vessel was most commonly a
eptal collateral channel, followed by epicardial vessels, and,
east commonly, bypass grafts (Table 1). Success in collat-
ral wire crossing was 81% for septal collaterals, 78% for
picardial collaterals, and 75% for bypass grafts. Subintimal
issection techniques (controlled antegrade and retrograde
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1275Table 1. Baseline Characteristics of the Study Patients, Classified According to Whether Technical Success
Was Achieved
Variable
Overall
(n  462)
Technical Success
(n  376)
Technical Failure
(n  86) p Value
Clinical characteristics
Age, yrs 65 9.7 65 9.9 68 8.8 0.138
Men 84.2 83 89.5 0.086
Hypertension 92 92 92 0.769
Hyperlipidemia 97.6 97.9 95.8 0.304
Diabetes 45 45.5 42.5 0.449
Heart failure 22.8 21.5 29.9 0.129
Ejection fraction 40% 18 16.3 26.9 0.006
History of MI 47.7 48.7 44.1 0.287
History of CABG 50 48.3 55.3 0.493
History of stroke 7.2 7 7.6 0.615
Prior PCI 45 45.9 40 0.66
Treatment center 0.001
Piedmont Heart Institute 27.5 (127) 25.0 (94) 38.4 (33)
St. Joseph Medical Center 58.4 (270) 62.7 (236) 39.5 (34)
Dallas Veterans Affairs Medical Center 14.1 (65) 12.2 (46) 22.1 (19)
Angiographic characteristics
CTO target vessel
RCA 66 66.2 62.8 0.27
LCX 18 18.1 17.4
LAD 15.5 15.2 17.4
LM/graft* 0.5 0.3 2.3
Prior failed attempt for CTO PCI 18 19 13 0.107
Retrograde crossing technique NA
Retrograde wire cross or kissing wire or antegrade
wire cross
41.3 42.7
CART 11.5 11.5
Reverse CART 47.2 46
Indications for retrograde approach 0.304
Complex lesion morphology (primary retrograde) 46 47 39.4
Failed antegrade approach 54 53 60.6
Collateral used 0.108
Septal 68 69 66
Epicardial 24 24 25
Bypass graft 8 7 9
Technical success 81.4 100 NA
Procedural success 79.4 97.6 NA
Intravascular ultrasound use 10 10 NA
Total stent length, mm* 72 35 NA NA
Number of stents implanted* NA 3.1 1.2 NA NA
Drug-eluting stents NA 96 NA NA
Bare-metal stents NA 4 NA NA
Balloon angioplasty only NA 4.6 NA NA
Total procedure time, min* 150 65 147 67 161 57 0.139
Total ﬂuoroscopy time, min* 61 40 58 40 72 36 0.003
Total contrast volume, ml, median (IQR) 300 (220, 430) 300 (200, 424) 375 (270, 520) 0.003
Values are mean SD, %, or % (n). *mean standard deviation.
CABG coronary artery bypass graft; CART controlled antegrade and retrograde tracking; CTO chronic total occlusion; IQR interquartile
range; LAD left anterior descending artery; LCX left circumflex artery; LM left main; MImyocardial infarction; NA not applicable; PCIpercutaneous coronary intervention; RCA right coronary artery.
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1276tracking [CART] and reverse CART) were used in 53% of
successful cases, whereas in the remaining cases, retrograde
wire crossing, kissing wire, or antegrade wire crossing was
performed (3,11–13).
The overall technical and procedural success rates were
81.4% (n 376) and 79.4% (n 367), respectively (Table 1).
he technical success rate for primary retrograde approach
as 83.4% versus 79.7% for retrograde attempts after
ntegrade crossing failure (p  0.34). Compared with
uccessful lesion treatment, technical failure was associated
ith reduced left ventricular function (Table 1). Contrast
olume and fluoroscopy time were significantly higher
mong technical failure cases (Table 1). The air kerma
adiation exposure was available in 270 patients and was 6.0
.9 Gy in technical success versus 7.2 3.1 Gy in technical
ailure cases (p 0.036). Among 2 of the 3 centers, a temporal
elationship in success was observed (Table 2, Fig. 1). On
ultivariable analysis, years since initiation of retrograde CTO
CI at each center, female sex, and ejection fraction 40%
ere the only variables that were independently associated with
echnical success (Table 3).
Table 4 details procedural-related complications. A major
dverse event occurred in 12 patients (2.6%), including 1
eath and 6 instances of cardiac perforation requiring either
ericardiocentesis or emergency surgery.
iscussion
The major findings of our study is that retrograde CTO
PCI can be performed in selected contemporary U.S.
centers with high success and low complication rates.
Table 2. Frequency and Technical Success of Retrog
and Calendar Year During Which the Procedures Wer
Center Year
Total CTO
PCI, n
St. Joseph Hospital 2006 100
2007 127
2008 108
2009 129
2010 138
2011 125
2006–2011 728
Piedmont Heart Institute 2010 154
2011 207
2010–2011 367
Veterans Affairs North Texas
Healthcare System
2008 39
2009 70
2010 95
2011 75
2008–2011 279
Total 2006–2011 1,374Abbreviations as in Table 1.Moreover, retrograde CTO PCI was frequently performed
in patients with prior bypass surgery and increasing experi-
ence with retrograde CTO PCI was associated with incre-
mental procedural success rates.
Technical success in the present study is comparable to
the rates from established CTO centers that range from
approximately 80% to nearly 100% and is more similar to
outcomes demonstrated in larger studies (Table 5). Given
that the retrograde approach was often performed in in-
stances of failed prior antegrade attempt or cases in which
CTO anatomy was unfavorable for antegrade recanaliza-
tion, the incremental contribution to overall CTO program
success is a clinically meaningful improvement. However,
unlike previous studies that describe the relative proportion
of retrograde procedures (26% in Japan (11) and 12% in
Europe (12)), the frequency of retrograde PCI in the
present study (34%) is higher, in part reflecting a high
frequency of failed antegrade crossing, but also suggest-
ing more common use of this approach as a primary
method (12).
Another distinction from previous studies performed
outside the United States is the considerably higher repre-
sentation of patients with prior coronary bypass surgery, an
observation that previously has been associated with a
higher likelihood of procedural failure (11). In particular,
the observed incidence of previous CABG was approxi-
mately 2- to 5-fold higher in the U.S. centers compared
with reports from Asia and Europe (14) (Table 5). Al-
though not identified as a predictor of procedural failure in
multivariable analysis in the present study, prior surgical
TO Interventions, Classified According by Center
formed
rograde
CI, n
Retrograde
CTO PCI, %
Technical Success Rate for
Retrograde CTO PCI, % (n/N)
9 9 44.4 (5/9)
26 20 85 (22/26)
40 37 77.5 (31/40)
67 52 82 (55/67)
67 49 98.5 (66/67)
61 49 93.5 (57/61)
270 37 87.4 (236/270)
61 40 73.7 (45/61)
66 32 74.4 (49/66)
127 35 74 (94/127)
6 15 17 (1/6)
11 16 100 (11/11)
28 29 61 (17/28)
20 27 85 (17/20)
65 23 71 (46/65)
462 34 81.4 (376/470)rade C
e Per
Ret
P
rventi
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 5 , N O . 1 2 , 2 0 1 2 Karmpaliotis et al.
D E C E M B E R 2 0 1 2 : 1 2 7 3 – 9 Multicenter Retrograde CTO PCI Registry
1277revascularization may confer greater lesion complexity due
to anatomical distortion of the native anatomy and acceler-
ation of native coronary artery atherosclerosis (15). The
observation also underscores an important role of CTO PCI
among patients with prior CABG who require repeat
coronary revascularization, commonly due to saphenous
vein graft failure. Repeat surgical coronary revascularization
can sometimes carry prohibitive risk (14) or is oftentimes
Figure 1. Temporal Trends in Technical Success of Retrograde Chronic Tot
Rate is Presented For Each Year For Each Participating Center and For All
Temporal trends in technical success of retrograde chronic total occlusion inte
Table 3. Multivariable Logistic Regression Analysis of Variables
Associated With Technical Success
Variable OR 95% CI p Value
Age, per 10-yr increase 0.73 0.52–1.01 0.061
Years since retrograde PCI started,
per 1-yr increase
1.63 1.32–2.04 <0.001
Men 0.34 0.01–0.92 0.034
Diabetes 1.06 0.59–1.89 0.855
Ejection fraction 40%, % 0.43 0.21–0.87 0.019
History of MI, % 1.10 0.62–1.97 0.738
History of CABG, % 0.99 0.54–1.79 0.976
Prior PCI, % 1.28 0.70–2.38 0.414
Bold values signify statistical significance.CI confidence interval; OR odds ratio; other abbreviations as in Table 1.unsuitable given occlusion of a vein graft to the CTO target
vessel with preserved patency of the internal mammary
graft. In some instances, native coronary CTO PCI may be
preferred in the setting of patent but degenerative saphe-
nous vein bypass grafts (16). Considering the risk of
periprocedural complications and eventual vein graft failure,
native coronary PCI may be associated with more favorable
outcome than bypass graft PCI (15).
There is currently controversy on whether “true to true”
lumen crossing should be used in all cases, with subintimal
dissection re-entry techniques only used as a last resort
(11,16). In the present series, wire crossing was achieved
using the CART or reverse CART technique in approxi-
mately one-half of the patients (Table 1).
In the present study, procedures were performed in 3 very
different hospital settings, including a rural hospital, a
metropolitan hospital, and a Veterans Affairs hospital,
suggesting that high success rates can be achieved across
varied institutional, administrative, and geographic back-
grounds. Importantly, as a measure of quality assurance, all
participating institutions adopted careful CTO PCI perfor-
mance guidelines, including careful attention to contrast
clusion Interventions Among the 3 Study Centers. The Technical Success
nters Combined
ons among the 3 study centers.al Oc
3 Ceand fluoroscopy use, patient selection, and post-procedural
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1278follow-up (16,17). Consistent with prior description of
CTO PCI (9), temporal assessment of procedural outcomes
suggests a learning curve to retrograde PCI that depends on
case volume (Tables 2 and 3, Fig. 1). In particular, improved
echnical success parallels annual experience and cumulative
rocedural volume.
Despite a larger sample size and inclusion of early
xperience, the procedural complication and in-hospital
dverse event rate of 2.6% is also consistent with published
eries (Table 5). Although the perceived risk of complica-
ions is a common deterrent to attempted CTO revascular-
zation, the overall complication rates appear to be similar
or CTO versus non-CTO PCI (18). Nevertheless, there
re complications unique to retrograde CTO PCI, such as
njury of the donor vessel, which can be a life-threatening
omplication (12). Global ischemia may also occur, related
o simultaneous interruption of collateral supply to the
arget vessel and impairment of blood flow or injury in the
onor vessel. Donor vessel dissection occurred in 2 patients
n our series (0.5%) and was treated conservatively in 1
atient, but required urgent CABG in the other patient.
nother retrograde CTO-specific complication is perfora-
ion of the collateral vessel that may result in septal
ematoma and tamponade (19). Overall, perforation requir-
ng pericardiocentesis or surgery occurred in 6 cases (1.3%),
ll of whom survived to hospital discharge. Another com-
lication unique to retrograde CTO PCI is equipment
ntrapment within a collateral vessel (20,21). This event
Table 4. Procedural Complications and In-Hospital Adverse Events
Complication n (%)
Any major procedural complication 12 (2.6)
Death 1 (0.2) Due t
Q-wave MI 2 (0.4) Treat
Donor vessel dissection 2 (0.4) 1 req
Equipment entrapment 1 (0.2) Requ
cre
Coronary artery perforations 6 (1.3) 4 req
Emergency cardiac surgery (included in the categories above) 3 (0.6) Due t
Abbreviations as in Table 1.
Table 5. Summary of Published Retrograde CTO PCI Series, Including >90
Study Year N
Prior
CABG, %
Septal Collaterals
Used, %
Reve
CART
Sianos et al. (8) 2008 175 10.9 79.4 NR
Rathore et al. (4) 2009 157 17.8 67.5 NR
Kimura et al. (5) 2009 224 17.6 79 14
Tsuchikane et al. (6) 2010 93 10.8 82.8 60
Morino et al. (21)* 2010 136 9.6 63.9 NR
Present study 2012 462 50.0 71 41
*Multicenter CTO registry in Japan: 136 of 529 procedures (25.7%) were retrograde.NR not reported; other abbreviations as in Table 1.ccurred in 1 patient (0.2%) causing a coronary-ventricular
stula that was successfully treated with coil embolization.
Study limitations. As with other retrograde CTO reports,
this analysis is limited by the retrospective and observational
design, in which unmeasured variables and potential for
treatment bias may influence the results. Angiographic core
laboratory quantitative coronary analyses were not per-
formed. Heterogeneity with regard to procedural outcome
and institution could indicate variability among individual
operators and case selection. Procedures were performed
over a period amid changes in operator experience and
techniques and in different institutions; however, these
findings also imply the generalizability of the study findings.
The 3 centers included in the present study have demon-
strated commitment to performing CTO PCI and have
gone through intensive and continuous training of the
operators and the cardiac catheterization laboratory person-
nel, and in each center, a single operator is involved in all or
in most CTO PCI cases. Finally, post-procedural biomark-
ers were not systematically ascertained, and angiographic-
dependent and clinical outcomes were not independently
adjudicated.
Conclusions
In summary, our series shows that among selected U.S.
programs, retrograde CTO PCI is often performed in
patients with prior coronary bypass graft surgery and is
Description
cranial bleeding
servatively
mergent CABG, and 1 was treated by stenting
il occlusion of a ﬁstula between a septal branch and the right ventricle that was
uring retrieval
ericardiocentesis and 2 emergent surgery
oration in 2 cases and due to donor vessel dissection in 1 case, as described above
nts
Technical
Success, %
Major
Complications, %
Fluoroscopy Time,
min, mean  SD
Contrast Use, ml,
mean  SD
83.4 4.6 59 29 421 167
84.7 4.5 NR NR
92.4 1.8 73 42 457 199
98.9 0 60 26 256 169
79.2 NR* NR* NR*
81.4 2.6 61 40 345 177o intra
ed con
uired e
ired co
ated d
uired p
o perfPatie
rse
, %
.9
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1279associated with favorably high success and low complication
rates.
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